A Swedish database of over 35,000 individuals found better cardiovascular outcomes when ezetimibe was added earlier to statin therapy for secondary prevention. Study authors deemed ezetimibe a ...
Please provide your email address to receive an email when new articles are posted on . Obicetrapib plus ezetimibe lowered LDL nearly 50% vs. placebo in patients with high atherosclerotic risk.
A recent simulation study published in the journal Scientific Reports analyzed representative data of over two million outpatients in Germany, in which the researchers reported that a combination of ...
The study was a randomized, placebo-controlled comparison of the effects of daily treatment with fenofibrate 160 mg, ezetimibe-simvastatin 10/20 mg, ezetimibe-simvastatin 10/20 mg plus fenofibrate 160 ...
The Effect of Combination Ezetimibe and High-Dose Simvastatin vs. Simvastatin Alone on the Atherosclerotic Process in Patients with Heterozygous Familial Hypercholesterolemia (ENHANCE) randomized ...
A strategy that combines high-intensity statin therapy with ezetimibe early after myocardial infarction results in a lower risk of recurrent events when contrasted with approaches that start ...
% differences compared with placebo or indicated statin are based on differences of individual least square means for LDL-C, HDL-C, non-HDL-C and apoB, and on differences of individual medians or ...
Please provide your email address to receive an email when new articles are posted on . Lerodalcibep, an investigational PCSK9 inhibitor, decreased LDL cholesterol on top of existing oral agents ...
SaveHealth reports on cholesterol medications, detailing common types like statins, their effects, and safety considerations ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback